Daiichi Sankyo Company Limited
Daiichi Sankyo's Enhertu drug shows strong sales growth, but faces pricing and market access hurdles. The company is also expanding its ADC linker capacity through a new partnership.
About Daiichi Sankyo Company Limited
Daiichi Sankyo Company Limited is a global pharmaceutical company focused on oncology.
Insights
- Daiichi Sankyo Company Limited sentiment is up 87.5% from the previous week.
- Daiichi Sankyo Company Limited mentions is up 47.06% from the previous week.
- Daiichi Sankyo Company Limited posts created is up 80% from the previous month.
- Daiichi Sankyo Company Limited Mentions hit a 52-Week high of [--] for the day
Price: $
Price 24-Hour Time-Series Raw Data
Daiichi Sankyo's stock fell 4.5% due to unchanged profit targets and pricing/market access challenges, compounded by potential tariffs on Japanese-made drugs. This is further supported by critical themes highlighting pricing and market access challenges.
1-Year High: $4,174 on 2025-10-09
1-Year Low: $2,836 on 2026-01-30
AltRank:
AltRank 24-Hour Time-Series Raw Data
Daiichi Sankyo Company Limited is currently AltRank # based on combined combined social and market metrics
Daily Average: [---]
1-Year High: [-----] on 2025-03-10
1-Year Low: [---] on 2025-12-25
Galaxy Score: [--]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [--] on 2025-02-25
1-Year Low: [--] on 2025-07-21
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] -92%
[--] Month: [-------] +1,189%
[--] Months: [-------] -96%
[--] Year: [----------] -51%
1-Year High: [---------] on 2025-03-31
1-Year Low: [--] on 2025-11-09
Engagements by network (24h): News: [--] Reddit: [--] YouTube: [--] X: [-----] Instagram: [--] TikTok: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +47%
[--] Month: [---] +34%
[--] Months: [---] +16%
[--] Year: [-----] +111%
1-Year High: [--] on 2026-02-12
1-Year Low: [--] on 2025-03-08
Mentions by network (24h): News: [--] Reddit: [--] YouTube: [--] X: [--] Instagram: [--] TikTok: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Daiichi Sankyo Company Limited in the last [--] hours which is down 8% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +4.40%
[--] Month: [---] +0.92%
[--] Months: [---] +12%
[--] Year: [---] +98%
1-Year High: [--] on 2025-12-18
1-Year Low: [--] on 2025-08-10
The most influential creators that mention Daiichi Sankyo Company Limited in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @grok | [--] | [----------] | [--] | [--] |
| @H2AK119ub | [--] | [--] | [--] |
Sentiment: 64%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 64%
Daily Average: 84%
[--] Week: 75% +35%
[--] Month: 55% -20%
[--] Months: 55% +14%
[--] Year: 55% -45%
1-Year High: 100% on 2025-02-19
1-Year Low: 36% on 2025-05-22
Most Supportive Themes:
- Oncology Pipeline Advancement: (40%) Daiichi Sankyo is making significant strides in its oncology pipeline, particularly with its antibody-drug conjugate (ADC) technology, leading to promising trial results and regulatory advancements.
- Strategic Partnerships and Collaborations: (30%) The company is actively engaging in strategic partnerships, notably with AstraZeneca, to co-develop and commercialize innovative cancer treatments, enhancing its market position and R&D capabilities.
- Market Expansion and Product Launches: (20%) Daiichi Sankyo is focused on expanding its market reach through new product launches and label expansions, as seen with Enhertu, indicating a strong commercial strategy and growing product portfolio.
Most Critical Themes:
- Pricing and Market Access Challenges: (70%) Despite promising trial data, Daiichi Sankyo faces challenges related to pricing and market access for its key drugs, as highlighted by the NICE decision regarding Enhertu, which could impact adoption rates.
- Competition in the Oncology Space: (30%) The oncology market is highly competitive, with numerous companies vying for market share. Daiichi Sankyo's success depends on maintaining its innovative edge and effectively differentiating its treatments.
Market Cap: $undefined
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $6,729,776,421,255
1-Year High: $7,065,992,123,959 on 2025-03-27
1-Year Low: $6,460,929,913,719 on 2025-02-20
Top Daiichi Sankyo Company Limited Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Recentemente si tenuto al Politecnico di Lecco levento WorkAbility Modelli e strategie per l'inserimento lavorativo in Italia e in Europa focalizzato sulla condivisione di buone prassi e sui modelli europei di accompagnamento al lavoro inclusivo. Ringraziamo Umana per averci dato la possibilit di portare la nostra testimonianza presentando il nostro approccio AmpiaMente descritto dal nostro HR CC & Mobility & Facilities Director @paolopagliarini. Il convegno ha rappresentato un momento ricco di stimoli di riflessioni interessanti e di condivisione di best practices sul tema della formazione e"
X Link @DaiichiSankyoIT 2026-02-16T10:07Z [----] followers, 16.1K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing